PE20040657A1 - Cefalosporinas - Google Patents

Cefalosporinas

Info

Publication number
PE20040657A1
PE20040657A1 PE2003000698A PE2003000698A PE20040657A1 PE 20040657 A1 PE20040657 A1 PE 20040657A1 PE 2003000698 A PE2003000698 A PE 2003000698A PE 2003000698 A PE2003000698 A PE 2003000698A PE 20040657 A1 PE20040657 A1 PE 20040657A1
Authority
PE
Peru
Prior art keywords
amino
alkyl
imino
compounds
fluorometoxy
Prior art date
Application number
PE2003000698A
Other languages
English (en)
Inventor
Gerd Ascher
Josef Wieser
Michael Schranz
Werner Heilmayer
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0216418A external-priority patent/GB0216418D0/en
Priority claimed from GB0222177A external-priority patent/GB0222177D0/en
Priority claimed from GB0223976A external-priority patent/GB0223976D0/en
Priority claimed from GB0223975A external-priority patent/GB0223975D0/en
Priority claimed from GB0223977A external-priority patent/GB0223977D0/en
Priority claimed from GB0223974A external-priority patent/GB0223974D0/en
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of PE20040657A1 publication Critical patent/PE20040657A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/38—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof
    • C07D501/46—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof with the 7-amino radical acylated by carboxylic acids containing hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A61K31/546—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine containing further heterocyclic rings, e.g. cephalothin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/38—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)

Abstract

SE REFIERE COMPOSICIONES FARMACEUTICAS QUE COMPRENDEN COMPUESTOS DE FORMULAS IA Y IB DONDE W ES CH, N; R1 ES HIDROXILO, ALCOXILO C1-C6, HALOALCOXILO C1-C6, ENTRE OTROS; R2 ES H O FRACCION DE ESTER; R3 ES H, ALQUILO C1-C6, ALQUENILO C2-C6, CICLOALQUILO C3-C8; R4 ES H O ALQUILO C1-C6; AES CICLOHEXILO O FENILO; R5 YR6 SON CADA UNO H, ALQUILO C1-C6, ALQUENILO C2-C6, ARILCARBONILO C6-C18, ENTRE OTROS; X ES NH, O, S, NR8; R8 ES ALQUILO C1-C6, CICLOALQUILO C3-C8; Y ES O, S; n Y m SON 0-1. SON COMPUESTOS PREFERIDOS: ACIDO 3-{(E) [[1-TRANS-(4-AMINO-CICLOHEXILAMINO)-IMINOMETIL]-METILHIDRAZONO]METIL}-7-{[(5-AMINO-1,2,4-TIADIAZOL-3-IL)-(Z)-(FLUOROMETOXI-IMINO)-ACETIL]AMINO}-3-CEFEM-4-CARBOXILICO; ACIDO 3-{(E) [[TRANS-4-AMINOCICLOHEXIL-IMINO)-METILTIOMETIL]-METILHIDRAZONO]METIL}-7-{[(5-AMINO-1,2,4-TIADIAZOL-3-IL)-(Z)-(FLUOROMETOXI-IMINO)-ACETIL]AMINO}-3-CEFEM-4-CARBOXILICO; ENTRE OTROS. DICHOS COMPUESTOS SON UTILES EN EL TATAMIENTO DE ENFERMEDADES MICROBIANAS
PE2003000698A 2002-07-15 2003-07-11 Cefalosporinas PE20040657A1 (es)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
GB0216418A GB0216418D0 (en) 2002-07-15 2002-07-15 Organic compound
GB0222177A GB0222177D0 (en) 2002-09-24 2002-09-24 Organic compounds
GB0223976A GB0223976D0 (en) 2002-10-15 2002-10-15 Organic compounds
GB0223975A GB0223975D0 (en) 2002-10-15 2002-10-15 Organic compounds
GB0223977A GB0223977D0 (en) 2002-10-15 2002-10-15 Organic compounds
GB0223974A GB0223974D0 (en) 2002-10-15 2002-10-15 Organic compounds

Publications (1)

Publication Number Publication Date
PE20040657A1 true PE20040657A1 (es) 2004-11-08

Family

ID=30119477

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2003000698A PE20040657A1 (es) 2002-07-15 2003-07-11 Cefalosporinas

Country Status (23)

Country Link
US (1) US7485632B2 (es)
EP (1) EP1529050B1 (es)
JP (1) JP2005536499A (es)
KR (1) KR20050037553A (es)
CN (1) CN1678616A (es)
AR (1) AR040545A1 (es)
AT (1) ATE327239T1 (es)
AU (1) AU2003250056A1 (es)
BR (1) BR0312698A (es)
CA (1) CA2492373A1 (es)
CO (1) CO5680481A2 (es)
DE (1) DE60305506T2 (es)
EC (1) ECSP055538A (es)
ES (1) ES2268429T3 (es)
HK (1) HK1077299A1 (es)
IL (1) IL166120A0 (es)
MX (1) MXPA05000664A (es)
NO (1) NO20050781L (es)
PE (1) PE20040657A1 (es)
PL (1) PL373104A1 (es)
SI (1) SI1529050T1 (es)
TW (1) TW200422044A (es)
WO (1) WO2004007505A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000189171A (ja) * 1998-12-25 2000-07-11 Banyu Pharmaceut Co Ltd 新規なグアノシン三リン酸（ｇｔｐ）結合タンパク質共役型のレセプタ―タンパク質
JP6580590B2 (ja) * 2014-04-16 2019-09-25 シーカ・テクノロジー・アーゲー アミジン基またはグアニジン基を含有するシラン

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5093989A (es) * 1973-10-25 1975-07-26
BR9608517A (pt) * 1995-05-11 1999-06-08 Biochemie Gmbh Cefalosporinas antibacterianas
GB0301938D0 (en) * 2003-01-28 2003-02-26 Biochemie Gmbh Organic compounds

Also Published As

Publication number Publication date
CA2492373A1 (en) 2004-01-22
DE60305506D1 (de) 2006-06-29
AU2003250056A1 (en) 2004-02-02
US7485632B2 (en) 2009-02-03
MXPA05000664A (es) 2005-04-25
KR20050037553A (ko) 2005-04-22
PL373104A1 (en) 2005-08-08
BR0312698A (pt) 2005-05-03
EP1529050B1 (en) 2006-05-24
ES2268429T3 (es) 2007-03-16
EP1529050A1 (en) 2005-05-11
TW200422044A (en) 2004-11-01
WO2004007505A1 (en) 2004-01-22
JP2005536499A (ja) 2005-12-02
ECSP055538A (es) 2005-03-10
US20050234233A1 (en) 2005-10-20
HK1077299A1 (en) 2006-02-10
SI1529050T1 (sl) 2006-10-31
AR040545A1 (es) 2005-04-13
IL166120A0 (en) 2006-01-15
NO20050781L (no) 2005-02-14
DE60305506T2 (de) 2007-04-19
CO5680481A2 (es) 2006-09-29
ATE327239T1 (de) 2006-06-15
CN1678616A (zh) 2005-10-05

Similar Documents

Publication Publication Date Title
AR011093A1 (es) Compuestos derivados de sulfonil urea, composicion farmaceutica que los contiene y procedimiento para su uso.
CO5550421A2 (es) Derivados de indol utiles para el tratamiento de enfermeda- des
HUP0203450A2 (hu) Pirazolo[4,3-d]pirimidin-származékok, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
AP9801302A0 (en) Indole compounds as anti-inflammatory/analgesic agents..
HUP0302380A2 (hu) Cisztein-proteázok reverzibilis inhibitoraiként alkalmazható új spiroheterociklusos vegyületek, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények
CO5600998A2 (es) Fluoropirrolidinas como inhibidores de dipeptidil peptidasa
TW200716531A (en) Cyclohexanesulfonyl derivatives as GLYT1 inhibitors to treat schizophrenia
FR2619111B1 (fr) Derives de (piperidinyl-4)methyl-2 tetrahydro-1,2,3,4 9h-pyrido (3,4-b) indole, leur preparation et leur application en therapeutique
ATE476431T1 (de) Piperidin- und azetidinderivate als glyt1- inhibitoren
CR8505A (es) Derivados de (3-oxo-3,4-dihidroquinoxalin-2-il-amino)-benzamida y compuesto relacionado, como inhibidores de glucogeno fosforilasa para el tratamiento de la diabetes y obesidad
MY140868A (en) Amide derivatives
TW200626553A (en) Novel compounds
HUP0300444A2 (hu) Kálciumblokkolót tartalmazó stabilizált gyógyszerkészítmények
PE20060455A1 (es) Nucleosidos de 3-beta-d-ribofuranosiltiazolo[4,5-d]pirimidina
BRPI0312882B8 (pt) derivados de pleuromutilina e composição farmacêutica
IL173810A0 (en) Imidazopyridine derivatives and pharmaceutical compositions containing the same
HUP0100470A2 (hu) Oxazolidinonszármazékok és ilyen vegyületeket tartalmazó gyógyászati készítmények
MXPA05012247A (es) Derivados de bencimidazol nuevos.
IL163625A0 (en) Alkoxy-pyridine derivatives and pharmaceutical compositions containing the same
NZ336623A (en) 2-amino-6-(2-substituted-4-phenoxy)-substituted-pyridines for use in the treatment and prevention of disorders of the central nervous system
NO20065030L (no) Aerosolformulering for inhalering av beta agonister.
IL173895A0 (en) Imidazopyridine derivatives and pharmaceutical compositions containing the same
NO20043951L (no) 3-cyklyl-5-(nitrogenholdig 5-leddet ring) metyl-oksazolidinon-derivater og deres anvendelse som antibakterielle midler
AR039475A1 (es) 6-alquiliden-penems triciclicos como inhibidores de beta-lactamasa
HUP0303204A2 (hu) 1-Metilkarbapenem-származékok és ezeket tartalmazó gyógyszerkészítmények

Legal Events

Date Code Title Description
FD Application declared void or lapsed